"Designing Growth Strategies is in our DNA"
Figure 01: Global Short Bowel Syndrome Market Revenue Breakdown (USD million, %) by Region, 2021 & 2029
Figure 02: Global Short Bowel Syndrome Market Value Share (%), By Type, 2021 & 2029
Figure 03: Global Short Bowel Syndrome Market Value Share (%), By Distribution Channel, 2021 & 2029
Figure 04: Global Short Bowel Syndrome Market Value Share (%), By Region, 2021 & 2029
Figure 05: North America Short Bowel Syndrome Market Value (USD million), by Type, 2021 & 2029
Figure 06: North America Short Bowel Syndrome Market Value Share (%), by Type, 2021
Figure 07: North America Short Bowel Syndrome Market Value (USD million), by Distribution Channel, 2021 & 2029
Figure 08: North America Short Bowel Syndrome Market Value Share (%), by Distribution Channel, 2021
Figure 09: North America Short Bowel Syndrome Market Value (USD million), by Country, 2021 & 2029
Figure 10: North America Short Bowel Syndrome Market Value Share (%), by Country, 2021
Figure 11: Europe Short Bowel Syndrome Market Value (USD million), by Type, 2021 & 2029
Figure 12: Europe Short Bowel Syndrome Market Value Share (%), by Type, 2021
Figure 13: Europe Short Bowel Syndrome Market Value (USD million), by Distribution Channel, 2021 & 2029
Figure 14: Europe Short Bowel Syndrome Market Value Share (%), by Distribution Channel, 2021
Figure 15: Europe Short Bowel Syndrome Market Value (USD million), by Country, 2021 & 2029
Figure 16: Europe Short Bowel Syndrome Market Value Share (%), by Country, 2021
Figure 17: Europe Short Bowel Syndrome Market Value (USD million), by Type, 2021 & 2029
Figure 18: Europe Short Bowel Syndrome Market Value Share (%), by Type, 2021
Figure 19: Asia Pacific Short Bowel Syndrome Market Value (USD million), by Distribution Channel, 2021 & 2029
Figure 20: Asia Pacific Short Bowel Syndrome Market Value Share (%), by Distribution Channel, 2021
Figure 21: Asia Pacific Short Bowel Syndrome Market Value (USD million), by Country, 2021 & 2029
Figure 22: Asia Pacific Short Bowel Syndrome Market Value Share (%), by Country, 2021
Figure 23: Japan Short Bowel Syndrome Market Value (USD million), by Type, 2021 & 2029
Figure 24: Japan Short Bowel Syndrome Market Value Share (%), by Type, 2021
Figure 25: Japan Short Bowel Syndrome Market Value (USD million), by Distribution Channel, 2021 & 2029
Figure 26: Japan Short Bowel Syndrome Market Value Share (%), by Distribution Channel, 2021
Figure 27: Europe Short Bowel Syndrome Market Value (USD million), by Type, 2021 & 2029
Figure 28: Europe Short Bowel Syndrome Market Value Share (%), by Type, 2021
Figure 29: Latin America Short Bowel Syndrome Market Value (USD million), by Distribution Channel, 2021 & 2029
Figure 30: Latin America Short Bowel Syndrome Market Value Share (%), by Distribution Channel, 2021
Figure 31: Latin America Short Bowel Syndrome Market Value (USD million), by Country, 2021 & 2029
Figure 32: Latin America Short Bowel Syndrome Market Value Share (%), by Country, 2021
Figure 33: Europe Short Bowel Syndrome Market Value (USD million), by Type, 2021 & 2029
Figure 34: Europe Short Bowel Syndrome Market Value Share (%), by Type, 2021
Figure 35: Middle East & Africa Short Bowel Syndrome Market Value (USD million), by Distribution Channel, 2021 & 2029
Figure 36: Middle East & Africa Short Bowel Syndrome Market Value Share (%), by Distribution Channel, 2021
Figure 37: Middle East & Africa Short Bowel Syndrome Market Value (USD million), by Country, 2021 & 2029
Figure 38: Middle East & Africa Short Bowel Syndrome Market Value Share (%), by Country, 2021
Figure 39: Global Short Bowel Syndrome Market Share (%), 2021
Table 01: Global Short Bowel Syndrome Market Revenue (USD million) Forecast, By Type, 2018–2029
Table 02: Global Short Bowel Syndrome Market Revenue (USD million) Forecast, By Distribution Channel, 2018–2029
Table 03: Global Short Bowel Syndrome Market Revenue (USD million) Forecast, By Region, 2018–2029
Table 04: North America Short Bowel Syndrome Market Revenue (USD million) Forecast, By Type, 2018–2029
Table 05: North America Short Bowel Syndrome Market Revenue (USD million) Forecast, By Distribution Channel, 2018–2029
Table 06: North America Short Bowel Syndrome Market Revenue (USD million) Forecast, By Country, 2018–2029
Table 07: U.S. - Prevalence, Treatment Ratio, and Patient Distribution, 2021–2029
Table 08: U.S. - Distribution of Number of Patients Treated by GLP-2 Brands, 2021–2029
Table 09: Canada - Prevalence, Treatment Ratio, and Patient Distribution, 2021–2029
Table 10: Europe Short Bowel Syndrome Market Revenue (USD million) Forecast, By Type, 2018–2029
Table 11: Europe Short Bowel Syndrome Market Revenue (USD million) Forecast, By Distribution Channel, 2018–2029
Table 12: Europe Short Bowel Syndrome Market Revenue (USD million) Forecast, By Country, 2018–2029
Table 13: Germany - Prevalence, Treatment Ratio, and Patient Distribution, 2021–2029
Table 14: France - Prevalence, Treatment Ratio, and Patient Distribution, 2021–2029
Table 15: U.K. - Prevalence, Treatment Ratio, and Patient Distribution, 2021–2029
Table 16: Italy - Prevalence, Treatment Ratio, and Patient Distribution, 2021–2029
Table 17: Spain - Prevalence, Treatment Ratio, and Patient Distribution, 2021–2029
Table 18: EU5 - Distribution of Number of Patients Treated by GLP-2 Brands, 2021–2029
Table 19: Asia Pacific Short Bowel Syndrome Market Revenue (USD million) Forecast, By Type, 2018–2029
Table 20: Asia Pacific Short Bowel Syndrome Market Revenue (USD million) Forecast, By Distribution Channel, 2018–2029
Table 21: Asia Pacific Short Bowel Syndrome Market Revenue (USD million) Forecast, By Country, 2018–2029
Table 22: China - Prevalence, Treatment Ratio, and Patient Distribution, 2021–2029
Table 23: Japan - Prevalence, Treatment Ratio, and Patient Distribution, 2021–2029
Table 24: South Korea - Prevalence, Treatment Ratio, and Patient Distribution, 2021–2029
Table 25: India - Prevalence, Treatment Ratio, and Patient Distribution, 2021–2029
Table 26: Australia - Prevalence, Treatment Ratio, and Patient Distribution, 2021–2029
Table 27: Southeast Asia - Prevalence, Treatment Ratio, and Patient Distribution, 2021–2029
Table 28: Japan Short Bowel Syndrome Market Revenue (USD million) Forecast, By Type, 2018–2029
Table 29: Japan Short Bowel Syndrome Market Revenue (USD million) Forecast, By Distribution Channel, 2018–2029
Table 30: Japan - Distribution of Number of Patients Treated by GLP-2 Brands, 2021–2029
Table 31: Latin America Short Bowel Syndrome Market Revenue (USD million) Forecast, By Type, 2018–2029
Table 32: Latin America Short Bowel Syndrome Market Revenue (USD million) Forecast, By Distribution Channel, 2018–2029
Table 33: Latin America Short Bowel Syndrome Market Revenue (USD million) Forecast, By Country, 2018–2029
Table 34: Middle East & Africa Short Bowel Syndrome Market Revenue (USD million) Forecast, By Type, 2018–2029
Table 35: Middle East & Africa Short Bowel Syndrome Market Revenue (USD million) Forecast, By Distribution Channel, 2018–2029
Table 36: Middle East & Africa Short Bowel Syndrome Market Revenue (USD million) Forecast, By Country, 2018–2029
Table 37: Rest of the World - Prevalence, Treatment Ratio, and Patient Distribution, 2021–2029
Related Reports